Literature DB >> 20690061

Automated analysis of tissue microarrays.

Marisa Dolled-Filhart1, Mark Gustavson, Robert L Camp, David L Rimm, John L Tonkinson, Jason Christiansen.   

Abstract

The analysis of protein expression in tissue by immunohistochemistry (IHC) presents three significant challenges. They are (1) the time-consuming nature of pathologist-based scoring of slides; (2) the need for objective quantification and localization of protein expression; and (3) the need for a highly reproducible measurement to limit intra- and inter-observer variability. While there are a variety of commercially available platforms for automated chromagen-based and fluorescence-based image acquisition of tissue microarrays, this chapter is focused on the analysis of fluorescent images by AQUA(R) analysis (Automated QUantitative Analysis) and the solutions offered by such a method for research and diagnostics. AQUA analysis is a method for molecularly defining regions of interest or "compartments" within a tissue section. The methodology can be utilized with tissue microarrays to provide rapid, quantitative, localized, and reproducible protein expression data that can then be used to identify statistically relevant correlations in populations. Ultimately this allows for a multiplexed, objective and standardized quantitative approach for biomarker research and diagnostic assay development for protein expression in tissue.

Mesh:

Substances:

Year:  2010        PMID: 20690061     DOI: 10.1007/978-1-60761-806-5_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  Image analysis of immunohistochemistry is superior to visual scoring as shown for patient outcome of esophageal adenocarcinoma.

Authors:  Annette Feuchtinger; Tabitha Stiehler; Uta Jütting; Goran Marjanovic; Birgit Luber; Rupert Langer; Axel Walch
Journal:  Histochem Cell Biol       Date:  2014-08-26       Impact factor: 4.304

2.  Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer.

Authors:  Jason R Brown; Michael P DiGiovanna; Brigid Killelea; Donald R Lannin; David L Rimm
Journal:  Lab Invest       Date:  2013-11-04       Impact factor: 5.662

3.  Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma.

Authors:  Douglas B Johnson; Jennifer Bordeaux; Ju Young Kim; Christine Vaupel; David L Rimm; Thai H Ho; Richard W Joseph; Adil I Daud; Robert M Conry; Elizabeth M Gaughan; Leonel F Hernandez-Aya; Anastasios Dimou; Pauline Funchain; James Smithy; John S Witte; Svetlana B McKee; Jennifer Ko; John M Wrangle; Bashar Dabbas; Shabnam Tangri; Jelveh Lameh; Jeffrey Hall; Joseph Markowitz; Justin M Balko; Naveen Dakappagari
Journal:  Clin Cancer Res       Date:  2018-07-18       Impact factor: 12.531

4.  Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.

Authors:  Jason R Brown; Hallie Wimberly; Donald R Lannin; Christian Nixon; David L Rimm; Veerle Bossuyt
Journal:  Clin Cancer Res       Date:  2014-09-25       Impact factor: 12.531

5.  Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure.

Authors:  Amy R Peck; Agnieszka K Witkiewicz; Chengbao Liu; Ginger A Stringer; Alexander C Klimowicz; Edward Pequignot; Boris Freydin; Thai H Tran; Ning Yang; Anne L Rosenberg; Jeffrey A Hooke; Albert J Kovatich; Marja T Nevalainen; Craig D Shriver; Terry Hyslop; Guido Sauter; David L Rimm; Anthony M Magliocco; Hallgeir Rui
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

6.  ZEB2 Represses the Epithelial Phenotype and Facilitates Metastasis in Ewing Sarcoma.

Authors:  Elizabeth T Wiles; Russell Bell; Dafydd Thomas; Mary Beckerle; Stephen L Lessnick
Journal:  Genes Cancer       Date:  2013-11

7.  High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy.

Authors:  Irina Gromova; Pavel Gromov; Naoko Honma; Sudha Kumar; David Rimm; Maj-Lis Møller Talman; Vera Timmermans Wielenga; José M A Moreira
Journal:  Mol Oncol       Date:  2015-05-14       Impact factor: 6.603

8.  Comparative evaluation of strategies for quantifying signaling pathway proteins in Ewing sarcoma.

Authors:  Mark A Applebaum; Dafydd G Thomas; Todd Hembrough; Jon Burrows; Andrew E Horvai; Elizabeth R Lawlor; Steven G DuBois
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-09

9.  Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the Pancreas.

Authors:  Edgar Ben-Josef; Asha George; William F Regine; Ross Abrams; Meredith Morgan; Dafydd Thomas; Paul L Schaefer; Thomas A DiPetrillo; Mitchel Fromm; William Small; Samir Narayan; Kathryn Winter; Kent A Griffith; Chandan Guha; Terence M Williams
Journal:  Clin Cancer Res       Date:  2015-08-03       Impact factor: 12.531

10.  High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer.

Authors:  Ming Liu; Gil Mor; Huan Cheng; Xue Xiang; Pei Hui; Thomas Rutherford; Gang Yin; David L Rimm; Jennie Holmberg; Ayesha Alvero; Dan-Arin Silasi
Journal:  Reprod Sci       Date:  2012-11-20       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.